8-KShareholder Matters

MCDONALDS CORP 8-K Report, Shareholder Vote Results (May 26, 2021)

Filed May 26, 2021For Securities:MCD

Summary

McDonald's Corporation (MCD) filed an 8-K on May 26, 2021, reporting the outcomes of its Annual Shareholders’ Meeting held on May 20, 2021. The key takeaway for investors is the overwhelming support for the company's slate of directors and its executive compensation practices. All twelve proposed directors were re-elected with substantial "For" votes, indicating shareholder confidence in the current leadership. Furthermore, shareholders provided an advisory approval for the compensation awarded to the company's named executive officers for 2020, signaling agreement with the company's compensation strategy. The appointment of Ernst & Young LLP as the independent auditor for 2021 was also overwhelmingly ratified, reinforcing transparency and trust in financial reporting. However, several shareholder proposals related to public health and corporate governance, specifically concerning sugar, antibiotics, and shareholder action by written consent, did not receive majority approval.

Key Highlights

  • 1All twelve nominated directors were re-elected for one-year terms, receiving significant shareholder support.
  • 2Shareholders approved, on an advisory basis, the compensation of McDonald's named executive officers for fiscal year 2020.
  • 3The appointment of Ernst & Young LLP as the independent auditor for 2021 was ratified with overwhelming approval.
  • 4Shareholder proposals requesting reports on sugar and public health, and on antibiotics and public health costs, were not approved.
  • 5A shareholder proposal seeking the ability for shareholders to act by written consent was also not approved.
  • 6The meeting confirmed strong shareholder confidence in the company's existing board and executive compensation structure.

Frequently Asked Questions

This 8-K filing reports the results of the matters voted on at McDonald's Corporation's Annual Shareholders' Meeting held on May 20, 2021. It details the voting outcomes for director elections, executive compensation, auditor ratification, and various shareholder proposals.

All twelve nominated directors were overwhelmingly re-elected. For each director, the 'For' votes significantly outnumbered the 'Against,' 'Abstain,' and 'Broker Non-Votes,' indicating strong shareholder confidence in the current board.

The proposal for an advisory vote to approve the compensation awarded to the Company's named executive officers for 2020 was approved by shareholders, with a substantial majority of 'For' votes.

No, the shareholder proposals requesting reports on sugar and public health, antibiotics and public health costs, and the ability for shareholders to act by written consent were all not approved. The 'Against' votes significantly outweighed the 'For' votes for these proposals.